Background: With the development of the surgical technique and experience of surgeons, uniportal VATS has been used in double sleeve lobectomy to treat non-small cell lung cancer (NSCLC). This retrospective study aims to evaluate the efficacy and safety of uniportal VATS in NSCLC treatment.
Methods: We reviewed 42 NSCLC patients who underwent double sleeve lobectomy in Shanghai Pulmonary Hospital from June 2015 to November 2017. 21 patients received double sleeve lobectomy through uniportal VATS and 21 through conventional thoracotomy with large incision.
Results: The characteristics of patients were similar between the two groups. The operation time was longer in the uniportal VATS group (p =0.021) and the drainage on postoperation day 1 was significantly less in the uniportal VATS group (p =0.004). Patients reported a lower postoperative pain level in the uniportal VATS group than in the thoracotomy group (p =0.002). No statistically significant difference showed in other aspects.
Conclusion: Uniportal VATS double sleeve lobectomy for NSCLC treatment is safe and effective. Lower postoperative pain level was found in the uniportal VATS group. Its complication rate and postoperation survival were similar to the conventional thoracotomy approach with large incision. But a large randomized clinical trial is still necessary for further investigation.
Keywords: sleeve lobectomy, uniportal video-assisted thoracic surgery, VATS, thoracotomy